• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在不依从和行政审查的随机试验中,对治疗对生存概率影响的推断。

Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.

作者信息

Nie Hui, Cheng Jing, Small Dylan S

机构信息

Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

Biometrics. 2011 Dec;67(4):1397-405. doi: 10.1111/j.1541-0420.2011.01575.x. Epub 2011 Mar 8.

DOI:10.1111/j.1541-0420.2011.01575.x
PMID:21385167
Abstract

In many clinical studies with a survival outcome, administrative censoring occurs when follow-up ends at a prespecified date and many subjects are still alive. An additional complication in some trials is that there is noncompliance with the assigned treatment. For this setting, we study the estimation of the causal effect of treatment on survival probability up to a given time point among those subjects who would comply with the assignment to both treatment and control. We first discuss the standard instrumental variable (IV) method for survival outcomes and parametric maximum likelihood methods, and then develop an efficient plug-in nonparametric empirical maximum likelihood estimation (PNEMLE) approach. The PNEMLE method does not make any assumptions on outcome distributions, and makes use of the mixture structure in the data to gain efficiency over the standard IV method. Theoretical results of the PNEMLE are derived and the method is illustrated by an analysis of data from a breast cancer screening trial. From our limited mortality analysis with administrative censoring times 10 years into the follow-up, we find a significant benefit of screening is present after 4 years (at the 5% level) and this persists at 10 years follow-up.

摘要

在许多有生存结局的临床研究中,当随访在预定日期结束且许多受试者仍存活时,就会发生行政删失。在一些试验中,另一个复杂情况是存在对分配治疗的不依从性。对于这种情况,我们研究在那些会依从治疗组和对照组分配的受试者中,治疗对直至给定时间点的生存概率的因果效应估计。我们首先讨论生存结局的标准工具变量(IV)方法和参数最大似然方法,然后开发一种有效的插件式非参数经验最大似然估计(PNEMLE)方法。PNEMLE方法不对结局分布做任何假设,并利用数据中的混合结构以比标准IV方法更有效。推导了PNEMLE的理论结果,并通过对一项乳腺癌筛查试验的数据进行分析来说明该方法。从我们在随访10年时进行行政删失时间的有限死亡率分析中,我们发现筛查在4年后(在5%水平)存在显著益处,并且在10年随访时这种益处仍然存在。

相似文献

1
Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.在存在不依从和行政审查的随机试验中,对治疗对生存概率影响的推断。
Biometrics. 2011 Dec;67(4):1397-405. doi: 10.1111/j.1541-0420.2011.01575.x. Epub 2011 Mar 8.
2
Performance of statistical methods for analysing survival data in the presence of non-random compliance.存在非随机依从性时分析生存数据的统计方法的性能。
Stat Med. 2010 Dec 20;29(29):2994-3003. doi: 10.1002/sim.4070. Epub 2010 Oct 20.
3
Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.工具变量估计量作为平均因果效应估计量的偏差分析。
Contemp Clin Trials. 2010 Jan;31(1):12-7. doi: 10.1016/j.cct.2009.10.003. Epub 2009 Oct 29.
4
Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.在存在不依从性的随机试验中评估安全性上限的因果推断方法。
Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.
5
Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?解读临床试验数据:反概率 censoring 加权分析能否解决交叉偏倚问题?
J Clin Oncol. 2012 Feb 1;30(4):453-8. doi: 10.1200/JCO.2010.34.2808. Epub 2012 Jan 3.
6
Impact of censoring on learning Bayesian networks in survival modelling.生存模型中删失数据对贝叶斯网络学习的影响。
Artif Intell Med. 2009 Nov;47(3):199-217. doi: 10.1016/j.artmed.2009.08.001. Epub 2009 Oct 14.
7
Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.随机试验中存在不依从时简单有效的有偏校正工具变量估计器。
Contemp Clin Trials. 2012 Jul;33(4):786-93. doi: 10.1016/j.cct.2012.03.013. Epub 2012 Mar 30.
8
Administrative and artificial censoring in censored regression models.删失回归模型中的管理性和人为删失
Stat Med. 2001 Aug 15;20(15):2287-304. doi: 10.1002/sim.850.
9
Nonparametric inference on median residual life function.关于中位数剩余寿命函数的非参数推断。
Biometrics. 2008 Mar;64(1):157-63. doi: 10.1111/j.1541-0420.2007.00826.x. Epub 2007 May 14.
10
Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.参与或未参与随机对照试验的乳腺癌患者的护理评估:法国国家抗癌联盟临床试验患者委员会的一份报告
J Clin Oncol. 2007 Jul 20;25(21):3038-44. doi: 10.1200/JCO.2006.08.9367. Epub 2007 May 29.

引用本文的文献

1
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low-income adults.工具变量分析在成本结果中的应用:在低收入成年人中,初级保健就诊对医疗费用的影响。
Stat Med. 2023 Oct 30;42(24):4349-4376. doi: 10.1002/sim.9865. Epub 2023 Aug 7.
2
Instrumental variable estimation of the marginal structural Cox model for time-varying treatments.用于时变治疗的边际结构Cox模型的工具变量估计
Biometrika. 2021 Dec 8;110(1):101-118. doi: 10.1093/biomet/asab062. eCollection 2023 Mar.
3
Estimation of causal quantile effects with a binary instrumental variable and censored data.
使用二元工具变量和删失数据估计因果分位数效应
J R Stat Soc Series B Stat Methodol. 2021 Jul;83(3):559-578. doi: 10.1111/rssb.12431. Epub 2021 Jul 1.
4
Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.解决具有点治疗设置的实用临床试验中治疗不依从性的分析方法:一项模拟研究。
BMC Med Res Methodol. 2022 Feb 16;22(1):46. doi: 10.1186/s12874-022-01518-8.
5
Causal Proportional Hazards Estimation with a Binary Instrumental Variable.使用二元工具变量的因果比例风险估计
Stat Sin. 2021 Apr;31(2):673-699. doi: 10.5705/ss.202019.0096.
6
Instrumental variable estimation of complier causal treatment effect with interval-censored data.工具变量法估计区间截断数据下的遵从性因果处理效应。
Biometrics. 2023 Mar;79(1):253-263. doi: 10.1111/biom.13565. Epub 2021 Oct 12.
7
Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument-outcome confounders.加权估计器对受限平均生存时间的遵嘱平均因果效应,考虑到观察到的工具-结局混杂因素。
Biom J. 2021 Apr;63(4):712-724. doi: 10.1002/bimj.201900284. Epub 2020 Dec 21.
8
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers.统计方法在调整时间事件结局和卫生技术评估中患者不依从性对治疗效果估计的应用:方法学论文的系统评价。
Med Decis Making. 2019 Nov;39(8):910-925. doi: 10.1177/0272989X19881654. Epub 2019 Oct 24.
9
A randomized placebo-controlled trial of vitamin D supplementation for reduction of mortality and cancer: Statistical analysis plan for the D-Health Trial.一项关于补充维生素D以降低死亡率和癌症风险的随机安慰剂对照试验:D-Health试验的统计分析计划。
Contemp Clin Trials Commun. 2019 Feb 20;14:100333. doi: 10.1016/j.conctc.2019.100333. eCollection 2019 Jun.
10
Estimating the Causal Effect of Treatment in Observational Studies with Survival Time Endpoints and Unmeasured Confounding.在具有生存时间终点和未测量混杂因素的观察性研究中估计治疗的因果效应。
J R Stat Soc Ser C Appl Stat. 2017 Jan;66(1):159-185. doi: 10.1111/rssc.12158. Epub 2016 Jun 27.